Retinoblastoma is a rare eye cancer affecting very young children, but with modern approaches to treatment, the outlook for these children has improved dramatically. Understanding the available treatment options—from established therapies to those being tested in clinical research—can help families navigate this challenging journey with hope and knowledge.

Understanding Treatment Goals for Retinoblastoma

When a child is diagnosed with retinoblastoma, the treatment team works toward three interconnected goals. The most important priority is always saving the child’s life. After that, doctors aim to preserve the affected eye whenever possible, and finally, they try to maintain as much vision as they can. This order matters because it guides every decision made during treatment planning.^[1]

Treatment decisions depend heavily on several factors. The medical team considers whether cancer affects one eye or both, how large the tumors are, where they are located within the eye, and whether cancer has spread beyond the eye. They also evaluate the child’s current vision in each eye and the stage of the disease. Each child’s situation is unique, which is why treatment plans are carefully tailored to individual needs.^[2]

The good news is that retinoblastoma is highly treatable when caught early. In specialized care centers, survival rates reach 95%, and vision can often be preserved. Medical societies have established standard treatment protocols that guide doctors in providing the best care. At the same time, researchers continue to explore new therapeutic approaches through clinical trials, offering hope for even better outcomes in the future.^[4]

Standard Treatment Approaches

The foundation of retinoblastoma treatment includes several well-established methods. The choice among these depends on the extent and location of the disease, and many children receive a combination of therapies rather than just one approach.

Chemotherapy

Chemotherapy uses powerful drugs to kill cancer cells or stop them from growing. This is the most common treatment for retinoblastoma and is often the first approach doctors try. The medication can be delivered in different ways depending on the child’s specific situation.^[12]

Intravenous chemotherapy involves injecting the drugs into a vein, usually in the arm, allowing the medicine to travel throughout the body. Some children receive this through a device called a port that doctors place in the chest. This method treats cancer cells wherever they may be in the body.^[12]

Intra-arterial chemotherapy is a more targeted approach. A specialist called a neuroradiologist inserts a thin, flexible tube into an artery in the hip or pelvis and carefully guides it to the artery that supplies blood to the eye. The chemotherapy then flows directly to the eye through this tube. This innovative technique delivers high concentrations of medicine directly where it’s needed while limiting exposure to the rest of the body. Children need to stay in the hospital for several hours after this treatment to recover.^[12]

Intraocular or intravitreal chemotherapy means doctors inject the medicine directly inside the eye. This approach is often used when tumor cells are floating in the fluid inside the eye, a condition called vitreous seeding. Doctors frequently combine this with other local treatments like laser therapy or freezing therapy.^[12]

The duration of chemotherapy varies based on how the tumor responds to treatment. Some children need only a few cycles, while others may require several months of therapy. Side effects can include nausea, temporary hair loss, increased infection risk due to lowered immune function, and fatigue. However, targeted delivery methods like intra-arterial chemotherapy often cause fewer side effects than traditional approaches because they spare much of the body from drug exposure.^[14]

Focal Therapies

Laser therapy uses focused light energy to heat and destroy cancer cells. Doctors can aim lasers directly at small tumors or use them to cut off the blood supply feeding the tumor. This causes the tumor to shrink and eventually die. Laser treatments are particularly useful for small tumors and can be repeated if necessary.^[12]

Cryotherapy, also called freeze therapy, uses extreme cold to kill cancer cells. During this procedure, doctors place a very cold metal probe on the surface of the eye near the tumor. They freeze and thaw the tumor several times, which destroys the cancer cells and helps prevent them from spreading outside the eye. This treatment works well for small to medium-sized tumors located in certain areas of the eye.^[12]

Radiation Therapy

Radiation therapy uses high-energy rays to kill cancer cells. There are two main types used for retinoblastoma. Internal radiation therapy, also called brachytherapy or plaque therapy, involves placing a small disc-shaped device behind the eye near the tumor. This device releases radiation directly to the cancer over several days, typically about seven. The radiation dose is concentrated on the tumor while minimizing exposure to surrounding healthy tissue. After the treatment period, doctors remove the implant.^[12]

External radiation therapy uses a machine outside the body to send radiation into the eye. However, this approach is less common today because radiation in very young children can cause significant long-term side effects. These may include cataracts, vision problems, facial bone growth abnormalities, and an increased risk of developing other cancers later in life. When possible, doctors try to avoid external radiation in children under three years old.^[13]

Surgery

When other treatments cannot control the cancer, or when the tumor is very large and threatens the child’s life, doctors may recommend surgical removal of the eye, a procedure called enucleation. This sounds frightening, but it can be life-saving when cancer has advanced too far for eye-preserving treatments to work effectively. Surgery may also be necessary if the tumor doesn’t respond to other treatments or if there’s a risk of cancer spreading beyond the eye.^[12]

After surgery, doctors place a special shield in the eye socket to protect it and hold it open while the tissue heals. About six weeks later, they replace the shield with an artificial eye, also called a prosthetic eye or ocular prosthesis. Modern artificial eyes look remarkably natural and move along with the other eye. While this is a significant adjustment for families, children who have had an eye removed can lead full, active lives.^[12]

Treatment in Clinical Trials

Clinical trials play a vital role in advancing retinoblastoma care. These carefully designed research studies test new treatments or new ways of using existing treatments to find approaches that may work better than current options. Participating in a clinical trial gives children access to cutting-edge therapies while contributing to medical knowledge that will help future patients.

Understanding Clinical Trial Phases

Clinical trials progress through different phases, each with a specific purpose. Phase I trials focus on safety. Researchers carefully study how the new treatment behaves in the body, what dose is appropriate, and what side effects occur. These trials typically involve small numbers of patients.^[9]

Phase II trials examine whether the treatment actually works against the cancer. Researchers look at how many patients’ tumors shrink or stop growing and continue monitoring for side effects. Phase III trials compare the new treatment directly to the current standard treatment to determine which approach provides better outcomes. These larger studies help establish whether a new therapy should become part of standard care.^[9]

Innovative Delivery Methods

One of the most significant advances in retinoblastoma treatment is supraselective intra-arterial chemotherapy. This technique requires exceptional skill because doctors must navigate arteries about the width of a strand of hair. Using specialized imaging technology, they guide a catheter through tiny blood vessels to deliver chemotherapy directly to the tumor.^[18]

This approach allows very high concentrations of cancer-fighting drugs to reach the tumor while protecting the rest of the body from exposure. Clinical studies have demonstrated that this method can successfully treat retinoblastoma while preserving the eye and avoiding the need for radiation in many cases. Children typically experience fewer side effects because the medication doesn’t circulate throughout their entire body. Research published in medical journals has confirmed that the drugs do indeed reach the tumor through this precise delivery route, validating the treatment’s mechanism of action.^[18]

Combination Therapy Approaches

Researchers are studying how to combine different treatments in the most effective ways. For example, some trials investigate using chemotherapy to shrink tumors followed by focal therapies like laser treatment or cryotherapy to eliminate remaining cancer cells. Others examine the best timing and sequencing of different drug combinations to maximize tumor destruction while minimizing side effects.^[13]

Clinical trials are also exploring whether certain chemotherapy drugs work better than others for specific types of retinoblastoma. For instance, researchers study different medication regimens for tumors that have invaded certain parts of the eye versus those that remain contained in the retina. This helps doctors tailor treatment more precisely to each child’s situation.^[13]

Advanced Disease Treatment

For children whose cancer has spread beyond the eye, researchers are investigating intensive treatment approaches. Some studies examine high-dose chemotherapy followed by autologous stem cell transplant. In this procedure, doctors collect the child’s own blood-forming stem cells before giving very high doses of chemotherapy that would normally destroy the bone marrow. After the chemotherapy, they return the stored stem cells to the child’s body, allowing the bone marrow to recover and begin producing healthy blood cells again.^[13]

This approach aims to deliver enough chemotherapy to eliminate cancer cells throughout the body while protecting the child’s ability to produce new blood cells. Clinical trials carefully monitor how well this strategy controls advanced disease and what long-term effects it may have. Early results suggest this can be effective for some children with cancer that has spread beyond the eye, though it requires intensive medical support.^[13]

Eligibility and Locations

Clinical trials for retinoblastoma are available at specialized centers around the world, including locations in the United States, Europe, and other regions. Eligibility criteria vary depending on the specific trial. Some studies enroll children newly diagnosed with retinoblastoma, while others focus on children whose cancer has returned after initial treatment or hasn’t responded to standard therapies.^[13]

Factors that determine eligibility may include the child’s age, whether cancer is in one or both eyes, the size and location of tumors, whether cancer has spread, and what treatments the child has already received. Families interested in clinical trials should discuss this option with their child’s oncology team, who can help identify appropriate studies and explain what participation would involve.^[9]

Most Common Treatment Methods

• Chemotherapy
  • Intravenous chemotherapy: drugs injected into a vein to circulate throughout the body
  • Intra-arterial chemotherapy: targeted delivery through the artery supplying the eye
  • Intravitreal chemotherapy: direct injection of medication into the eye
  • Most common first-line treatment approach for retinoblastoma
  • Often combined with focal therapies for maximum effectiveness
• Focal Therapies
  • Laser therapy: uses focused light energy to heat and destroy cancer cells or cut off blood supply to tumors
  • Cryotherapy: freezing and thawing cycles that kill cancer cells
  • Particularly effective for small to medium-sized tumors
  • Can be repeated if necessary
  • Often used in combination with chemotherapy
• Radiation Therapy
  • Internal radiation (brachytherapy): radioactive disc placed behind the eye for about seven days
  • External radiation: less commonly used due to long-term side effect concerns in young children
  • Reserved for situations where other treatments cannot control the cancer
• Surgery
  • Enucleation: surgical removal of the affected eye
  • Recommended when tumors are too large for eye-preserving treatments
  • Necessary if cancer threatens the child’s life or has spread beyond the eye
  • Followed by placement of an artificial eye after healing period
• Advanced Clinical Trial Approaches
  • Supraselective intra-arterial chemotherapy with advanced imaging guidance
  • Novel drug combinations and sequences
  • High-dose chemotherapy with stem cell rescue for advanced disease
  • Improved focal therapy techniques

Side Effects and Long-Term Considerations

Every treatment for retinoblastoma can cause side effects, though their severity varies depending on the specific approach used and each child’s individual response. Understanding potential side effects helps families prepare and know what to watch for during treatment.

Chemotherapy side effects depend on which drugs are used and how they’re delivered. Intravenous chemotherapy may cause nausea, vomiting, temporary hair loss, increased susceptibility to infections, bruising or bleeding due to low blood cell counts, and fatigue. Targeted delivery methods like intra-arterial chemotherapy typically cause milder side effects because less of the drug reaches the rest of the body. Some children may experience temporary inflammation or swelling in the treated eye.^[14]

Focal therapies generally cause fewer systemic side effects but can affect the treated area of the eye. Laser therapy may temporarily cause swelling or inflammation in the eye. Cryotherapy can also lead to eye swelling and, in some cases, may affect the eye’s ability to produce tears. These local effects usually resolve over time as the eye heals.^[14]

Radiation therapy in young children raises concerns about long-term effects. These may include cataracts developing in the lens of the eye, damage to the retina leading to vision problems, abnormal bone growth in the face and skull, dry eyes, and an increased risk of developing other cancers later in life. Because of these potential complications, doctors try to avoid radiation when possible, especially in children under three years old.^[15]

Children who have heritable retinoblastoma face an elevated risk of developing other types of cancer throughout their lives, including bone cancer called osteosarcoma, soft tissue sarcomas, melanoma, and other malignancies. This risk exists because of the underlying genetic mutation rather than the treatment itself, though radiation therapy can increase the risk further. Regular screening and health monitoring throughout life are important for these children as they grow into adulthood.^[7]

Life After Treatment

The journey doesn’t end when active treatment stops. Retinoblastoma survivors and their families face ongoing considerations related to vision, development, and overall health. However, with appropriate support and monitoring, children treated for retinoblastoma can thrive and lead fulfilling lives.

Vision outcomes vary widely depending on the location and size of the original tumors and which treatments were necessary. Some children maintain good vision in their affected eye, while others experience significant vision loss even when the eye is preserved. Children who had one eye removed can adapt remarkably well, though they may need accommodations for depth perception and peripheral vision limitations. Early intervention with vision specialists and occupational therapists can help children develop strategies to navigate their world successfully.^[16]

Regular follow-up care is essential after treatment ends. Young children need frequent eye examinations to watch for new tumors, which can develop during the first few years after diagnosis in children with hereditary retinoblastoma. These exams typically occur every two to four months for at least 28 months after the initial diagnosis. As children grow older, the frequency of these exams may decrease, but regular monitoring continues to ensure any problems are caught early.^[9]

Psychological and emotional support plays a crucial role in helping families adjust to life after retinoblastoma. Parents often experience anxiety about their child’s future, whether cancer will return, and how vision loss might affect their child’s development and quality of life. Children themselves may struggle with feeling different from their peers, especially if they wear an artificial eye or have significant vision impairment. Connecting with support groups, counseling services, and other families who have been through similar experiences can provide comfort and practical guidance.^[19]

School-age survivors may need educational support and accommodations. Teachers should understand the child’s vision capabilities and any special needs. Some children benefit from preferential seating, large-print materials, extra time for visual tasks, or assistive technology. Most children with retinoblastoma history can participate fully in school activities with appropriate support. Many survivors go on to excel academically and professionally, demonstrating that retinoblastoma doesn’t have to limit a person’s potential.^[19]

Survivors describe their experience with retinoblastoma as a defining but not limiting part of their lives. Many adults who were treated as children emphasize that while they carry the effects of their illness and treatment, they’ve found ways to adapt and thrive. They pursue careers, build families, and engage in activities they’re passionate about. Access to resources for blind and visually impaired individuals, when needed, opens many doors for education, employment, and independent living.^[16]